Supporting our finding, p53 interacts with PPAR-γ co-activator 1α (PGC-1α) [45,46,47], and PPAR activator promotes the differentiation of mesenchymal therapy-resistant breast cancer cells [25]. This evidence concerns the gene TP53 and breast cancer.